Expression of Mutated Huntingtin Fragment in the Putamen Is Sufficient to Produce Abnormal Movement in Non-human Primates
Open Access
- 1 August 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (8) , 1444-1451
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Huntingtin–protein interactions and the pathogenesis of Huntington's diseaseTrends in Genetics, 2004
- Mouse models of Huntington's diseaseTrends in Pharmacological Sciences, 2002
- Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's diseasePhilosophical Transactions of the Royal Society B: Biological Sciences, 1999
- Chronic 3-Nitropropionic Acid Treatment in Baboons Replicates the Cognitive and Motor Deficits of Huntington’s DiseaseJournal of Neuroscience, 1996
- Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkeyNeurodegeneration, 1995
- Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.Proceedings of the National Academy of Sciences, 1995
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's diseaseJournal of the Neurological Sciences, 1990
- Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 1984
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences, 1983